Literature DB >> 19771266

Overexpression of alpha1-protease inhibitor and galectin-1 in radiation-induced early phase of pulmonary fibrosis.

Hee-Soon Im1, Hyung-Doo Kim, Jie-Young Song, Youngsoo Han, Do-Youn Lee, Chan-Wha Kim, Yeon-Sook Yun.   

Abstract

PURPOSE: Radiation-induced pulmonary fibrosis (RIF) is a significant complication of radiotherapy for lung cancer. Despite the large number of studies, the molecular mechanisms of RIF are poorly understood. Therefore, the complex protein expression pattern in RIF was characterized by identifying the proteins with an altered expression level after thorax irradiation using two-dimensional electrophoresis (2-DE) and mass spectrometry.
MATERIALS AND METHODS: A mouse model of RIF was used to examine the alteration of the lung proteome because of availability of murine data related to human cases and the abundance of murine fibrotic lung samples. A mouse model of RIF was induced in radiosensitive C57BL/6 mice. Twenty-one weeks after 25 Gy irradiation, hematoxylin-eosin staining and hydroxyproline assay confirmed the early-phase pulmonary fibrosis.
RESULTS: Lung samples from the irradiated and age-matched control mice were used to generate 16 high quality 2-DE gels containing approximately 1,000 spots. Of the 31 significantly up- or down-regulated protein spots, 17 were identified by MALDI-TOF/MS.
CONCLUSIONS: Two important upregulated proteins were found, the alpha1-protease inhibitor and galectin-1, which might be used as potential markers for the early phase of RIF.

Entities:  

Keywords:  Galectin-1; Radiation-induced pulm onary fibrosis; proteomics; α1-protease inhibitor

Year:  2006        PMID: 19771266      PMCID: PMC2741661          DOI: 10.4143/crt.2006.38.2.92

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  25 in total

1.  Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity.

Authors:  F Gharahdaghi; C R Weinberg; D A Meagher; B S Imai; S M Mische
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

Review 2.  Update in pulmonary medicine.

Authors:  T E King
Journal:  Ann Intern Med       Date:  1998-11-15       Impact factor: 25.391

3.  Immunocytochemical evidence for a modulation of galectin 3 (Mac-2), a carbohydrate binding protein, in pulmonary fibrosis.

Authors:  M Kasper; R C Hughes
Journal:  J Pathol       Date:  1996-07       Impact factor: 7.996

4.  A simplified method for the analysis of hydroxyproline in biological tissues.

Authors:  G K Reddy; C S Enwemeka
Journal:  Clin Biochem       Date:  1996-06       Impact factor: 3.281

5.  Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice.

Authors:  Y Taooka; A Maeda; K Hiyama; S Ishioka; M Yamakido
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

6.  Neutrophil elastase: alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis.

Authors:  H Yamanouchi; J Fujita; S Hojo; T Yoshinouchi; T Kamei; I Yamadori; Y Ohtsuki; N Ueda; J Takahara
Journal:  Eur Respir J       Date:  1998-01       Impact factor: 16.671

7.  Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation.

Authors:  A J Franko; J Sharplin; A Ghahary; M H Barcellos-Hoff
Journal:  Radiat Res       Date:  1997-02       Impact factor: 2.841

Review 8.  The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway.

Authors:  Sylvie Delanian; Jean-Louis Lefaix
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280

9.  Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis.

Authors:  Amir Abdollahi; Minglun Li; Gong Ping; Christian Plathow; Sophie Domhan; Fabian Kiessling; Leslie B Lee; Gerald McMahon; Hermann-Josef Gröne; Kenneth E Lipson; Peter E Huber
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

10.  Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis.

Authors:  G A Rabinovich; G Daly; H Dreja; H Tailor; C M Riera; J Hirabayashi; Y Chernajovsky
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.